Gregory Friedman
Professor, and Zhuo · University of Texas M D Anderson Cancer Center
Credentials: · · ·
History
Pediatrics
Research
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
New England Journal of Medicine · 2021 · First of 28 authors · 288 citations
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Review · Theranostics · 2021 · 189 citations
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Review · Neurotherapeutics · 2017 · 106 citations
- JB
48 papers · 45 as a resident
32 papers
19 papers
12 papers
10 papers
10 papers
9 papers
9 papers · 9 as a resident
Grants
- 2026–2031
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $421.4K · University of Tx Md Anderson Can Ctr
- 2019–2027
Ph1 Study of HSV G207 in Pediatric Malignant Cerebellar Tumors IND 16294 01/05/18.
Food and Drug Administration · R01
Contact PI · $750K · University of Tx Md Anderson Can Ctr
- 2016–2022
Ph1 of HSV G207 and Radiation to Treat Pediatric Brain Tumors IND16294 (12/10/14)
Food and Drug Administration · R01
Contact PI · $749.8K · University of Alabama at Birmingham
Clinical trials
- 2026–2032
Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas
Principal investigator · Not yet recruiting · Phase 2
M.D. Anderson Cancer Center
- 2026–2031
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
- 2025
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Principal investigator · Withdrawn · Phase 2
Pediatric Brain Tumor Consortium
- 2019–2027
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center